Biocept: Why Is Liquid Biopsy Firm Biocept Stock Trading Lower Today?

Biocept Inc (NASDAQ: BIOC) filed for Chapter 7 bankruptcy in the U.S. Bankruptcy Court for the District of Delaware. In a document filed with the U.S. Securities and Exchange Commission, the company said it is filing its petition after considering strategic alternatives. Antonino Morales resigned as the company's president and CEO, while Marsha Chandler, Bruce Gerhardt, Quyen Dao-Haddock, Ivor Royston, and Linda Rubinstein resigned from Biocept's board of directors on the same day. A Chapter 7 bankruptcy discharge ...Full story available on Benzinga.com